908 Devices Inc (MASS) News

Form 8-K - Current report

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

Fourth quarter 2023 revenue increased 23% compared to prior year, driven by handheld revenue increasing 57% 908 Devices Inc. (Nasdaq: MASS), a...

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and Cellares, the...

Form 4 - Statement of changes in beneficial ownership of securities

908 Devices to Participate in Upcoming Investor Conferences

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced...

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

908 Devices Announces MX908 Integration Capabilities

Broadens the reach of trace detection and identification at the point of need to enhance safety 908 Devices Inc. (Nasdaq: MASS), a pioneer of...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report